AI Analysis AI Analysis of VYNE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VYNE to Watchlist?
Some Reasons Why To Add VYNE:
  • 79.06% TTM dividend yield
  • High gross margin of 98.7%
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Volatile ride for Vyne Therapeutics Inc stock price on Friday moving between $0.470 and $0.549
(Updated on Jul 24, 2026)

Sell candidate since Jul 24, 2026

The Vyne Therapeutics Inc stock price fell by -44.88% on the last day (Friday, 24th Jul 2026) from $0.92 to $0.509. During the last trading day the stock fluctuated 16.77% from a day low at $0.470 to a day high of $0.549. The price has risen in 8 of the last 10 days but is still down by -20.17% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $1.41 million.

Given the current short-term trend, the stock is expected to rise 10.14% during the next 3 months and, with a 90% probability hold a price between $0.561 and $1.02 at the end of this 3-month period.

VYNE Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vyne Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.794 and $0.687. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 23, 2026, and so far it has fallen -44.88%. Further fall is indicated until a new bottom pivot has been found. Vyne Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Vyne Therapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0788 between high and low, or 16.77%. For the last week, the stock has had daily average volatility of 12.48%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VYNE) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Vyne Therapeutics Inc to open at $0.509, and during the day (based on 14 day Average True Range), to move between $0.469 and $0.549, which gives a possible trading interval of +/-$0.0803 (+/-17.12%) up or down from last closing price. If Vyne Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 17.12% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.622, some $0.113 (22.20%) from the current price of $0.509, our system finds the risk reward not very attractive.

Is Vyne Therapeutics Inc stock A Buy?

The Vyne Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Vyne Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.719 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $0.509 ( 0.0524%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VYNE Performance

Trading levels for VYNE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.588 15.53%
R2 0.558 9.62%
R1 0.539 5.97%
Price 0.509
S1 0.479 -5.86%
S2 0.461 -9.52%
S3 0.430 -15.43%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.635 24.83%
R2 0.633 24.34%
R1 0.622 22.20%
Price 0.509
S1 0 -
S2 0 -
S3 0 -

VYNE Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 24, 2026 Jul 24, 2026 Jul 24, 2026 $0.402 44.83%
2 Jul 22, 2026 Jul 22, 2026 Jul 23, 2026 $0.380 57.76%

FAQ

What is the symbol for Vyne Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Vyne Therapeutics Inc is VYNE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vyne Therapeutics Inc Stock?
The Vyne Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Vyne Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Vyne Therapeutics Inc Stock?
Vyne Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vyne Therapeutics Inc Stock.

What's the current price of Vyne Therapeutics Inc Stock?
As of the end of day on the Jul 24, 2026, the price of an Vyne Therapeutics Inc (VYNE) share was $0.509.

What is the 52-week high and low for Vyne Therapeutics Inc Stock?
The 52-week high for Vyne Therapeutics Inc Stock is $1.60 and the 52-week low is $0.281.

What is the market capitalization of Vyne Therapeutics Inc Stock?
As of the Jul 24, 2026, the market capitalization of Vyne Therapeutics Inc is 8.482M.

When is the next earnings date for Vyne Therapeutics Inc?
The upcoming earnings date for Vyne Therapeutics Inc is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT VYNE THERAPEUTICS INC
Vyne Therapeutics
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is als...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
1.37% Jul 21
N
NVDU
$126.01
1.17% Jul 21
DHT
$17.31
6.35% Jul 13
JLL
$299.78
6.54% Jun 24
ROP
$331.60
7.09% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE